Form 4: Director Keith R. Harris Exercises MeiraGTx RSUs

Director Keith R. Harris acquired 75,000 ordinary shares of MeiraGTx Holdings plc through the vesting of restricted share units.

Summary

• Director Keith R. Harris exercised 75,000 restricted share units (RSUs) on June 10, 2026.
• Each RSU converted into one ordinary share of MeiraGTx Holdings plc.
• Following the transaction, the reporting person holds a total of 200,000 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents the routine vesting of director compensation rather than a discretionary market purchase or sale.

Positives

• Director maintains a significant equity stake of 200,000 shares, aligning interests with shareholders.

Negatives

• None identified in this filing.

Risks

• The value of the acquired shares is subject to market volatility and the company's future clinical and commercial performance.

Future Outlook

The filing does not provide forward-looking guidance regarding company operations or financial performance.

Industry Context

StockSavvy.ai notes that director equity vesting is a standard component of executive and board compensation packages in the biotechnology sector, reflecting long-term incentive alignment.

Comparison to Industry Standards

• The transaction follows standard corporate governance practices for equity-based compensation in the biotech industry.
• The vesting schedule is consistent with typical annual director compensation structures for publicly traded life sciences companies.

Stakeholder Impact

• The transaction increases the director's direct ownership, which may be viewed positively by shareholders as a sign of commitment.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

MeiraGTx, MGTX, Insider Trading, Form 4, Director, Equity Compensation